New biocompatible titanium alloys for next-generation metallic biomaterials

用于下一代金属生物材料的新型生物相容性钛合金

• 批准号: DP210101862
• 负责人: Prof Cuie Wen
• 金额: $ 33.8万
• 依托单位: RMIT University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2024-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP210101862
• 关键词: New; biocompatible; titanium; alloys; next

This project aims to develop a new class of titanium alloy biomaterials with enhanced mechanical compatibility, biocompatibility, and bio-functionality. The project expects to generate new knowledge in phase transformation mechanisms and advanced surface modification techniques for these alloys. Expected outcomes also include developments in phase transformation theories that enable high yield strength and low Young's modulus, and innovations in manufacturing techniques for new titanium alloys. This project will provide significant benefits to both Australian healthcare providers and bone-implant recipients through greater implant lifespans, improved patient outcomes and valuable savings to the healthcare system.

本项目旨在开发一种新型钛合金生物材料，具有增强的机械相容性，生物相容性和生物功能性。该项目预计将在这些合金的相变机制和先进的表面改性技术方面产生新的知识。预期成果还包括相变理论的发展，使高屈服强度和低杨氏模量，以及新钛合金制造技术的创新。该项目将为澳大利亚医疗保健提供者和骨植入物接受者提供显着的好处，通过更长的植入寿命，改善患者的治疗效果和为医疗保健系统节省宝贵的费用。